Skye Bioscience Inc (SKYE)

[lithiumjr]

InMed Comparables
From the InMed April presentation, slide 20
http://www.inmedpharma.com/i/pdf/presentations/InMed-April-Investor.pdf

INMED (IMLFF)
Drug Discovery Platform: YES
Proprietary Delivery System: YES
Completed Pre-clinical Therapies: 2
Pre Clinical Therapies: 5
Total Therapy Pipeline: 12
Federally Legalized Status: YES
Market Cap: 15M

http://www.inmedpharma.com/s/pipeline.asp

NEMUS BIOSCIENCE (OTC NMUS)
Drug Discovery Platform: NO
Proprietary Delivery System: NO
Completed Pre-clinical Therapies: 0
Pre Clinical Therapies: 2
Total Therapy Pipeline: 5
Federally Legalized Status: NO
Market Cap: 62.6M

See bottom page drug pipeline
http://nemusbioscience.com/services.html

ZYNERBA (Private Co)
Drug Discovery Platform: NO
Proprietary Delivery System: YES
Completed Pre-clinical Therapies: 0
Pre Clinical Therapies: 2
Total Therapy Pipeline: 2
Federally Legalized Status: n/a
Market Cap: 70M

Our development pipeline currently includes two preclinical programs studying synthetic cannabinoid therapeutics.
http://zynerba.com/in-development/


CANNABIS SCIENCE (OTC CBIS)
Drug Discovery Platform: NO
Proprietary Delivery System: NO
Completed Pre-clinical Therapies: 0
Pre Clinical Therapies: 3
Total Therapy Pipeline: 3
Federally Legalized Status: NO
Market Cap: 40.9M

http://www.cannabisscience.com/index.php/research-development/programs/cs-tati-1

Read more at http://www.stockhouse.com/companies/bullboard/c.in/inmed-pharmaceuticals-inc#57g6TO2dDXo7cIhI.99